Blog

»  Posts By   2019 

Plan Sponsor ALERT: Beware of Rebate Aggregators

Plan Sponsors should be aware of a few recent developments that lead to higher net gross and net drug prices. First, the White House recently withdrew a Notice of Proposed Rule Making (NPRM) that would have altered the entire drug marketplace. The NPRM would have eliminated the "Safe Harbor" that permits Pharmacy Benefit Managers (PBMs) to legally extract billions of dollars in "rebate" from Manufacturers in exchange for securing drugs...

Frier Levitt Expands National Footprint with the Opening of New Manhattan Office

As part of its continued expansion, national boutique healthcare law firm Frier Levitt announced today the opening of a new Downtown Manhattan office located at 101 Greenwich Street. 101 Greenwich Street is a LEED Silver Certified Class A property in the Financial District of Lower Manhattan featuring state-of-the-art technology and best-in-class hospitality and amenities. Frier Levitt's new Manhattan office will be headed by long-time partner John E. Morrone, Esq. who...

Private Equity in Orthopedics: Before, During, and After the Transaction Webinar Recording

https://www.youtube.com/watch?v=fB23dMzbBtY&feature=youtu.be   As private equity looks to replicate its successes across specialty physician services, significant investment activity has begun to occur in the orthopedic sector. The goal of these transactions is to create an alignment between clinically leading orthopedic groups and private equity firms to position the practice for growth and success in the ever-changing health care environment. This webinar provides an update on the current state of the market,...

340B Contracting in an Age of DIR Fees and Predatory Pricing

The 340B program is a federal discount drug program which requires pharmaceutical manufacturers to enter into an agreement, called a Pharmaceutical Pricing Agreement (PPA), with the Secretary of the Department of Health & Human Services in exchange for having their drugs covered by Medicaid and Medicare Part B. Under the PPA, the drug manufacturer agrees to provide front-end discounts on drugs purchased by "covered entities," which typically serve the nation's...

Frier Levitt Successfully has Patient Neglect Charges Dropped for RN

Frier Levitt recently represented a Registered Nurse who was charged with patient neglect at a residency for the cognitively impaired. After working with the prosecutor, Frier Levitt was able to prove the charges were unsubstantiated and the prosecutor agreed to drop all charges against our client. Frier Levitt routinely represents healthcare professionals facing allegations of neglect and misconduct. Contact Frier Levitt today to speak to an attorney.